Dexniguldipine

Drug Profile

Dexniguldipine

Alternative Names: B 859035

Latest Information Update: 20 May 1996

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ALTANA Pharma
  • Class Chemosensitisers; Dihydropyridines
  • Mechanism of Action Calmodulin antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Acute myeloid leukaemia; Multiple myeloma

Most Recent Events

  • 20 May 1996 Discontinued-II for Acute myeloid leukaemia in European Union (Unknown route)
  • 20 May 1996 Discontinued-II for Acute myeloid leukaemia in USA (Unknown route)
  • 20 May 1996 Discontinued-II for Multiple myeloma in European Union (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top